Table of Content
1 Pharmacogenomics Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Pharmacogenomics Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Pharmacogenomics Market Forces
3.1 Global Pharmacogenomics Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Pharmacogenomics Market - By Geography
4.1 Global Pharmacogenomics Market Value and Market Share by Regions
4.1.1 Global Pharmacogenomics Value ($) by Region (2015-2020)
4.1.2 Global Pharmacogenomics Value Market Share by Regions (2015-2020)
4.2 Global Pharmacogenomics Market Production and Market Share by Major Countries
4.2.1 Global Pharmacogenomics Production by Major Countries (2015-2020)
4.2.2 Global Pharmacogenomics Production Market Share by Major Countries (2015-2020)
4.3 Global Pharmacogenomics Market Consumption and Market Share by Regions
4.3.1 Global Pharmacogenomics Consumption by Regions (2015-2020)
4.3.2 Global Pharmacogenomics Consumption Market Share by Regions (2015-2020)
5 Pharmacogenomics Market - By Trade Statistics
5.1 Global Pharmacogenomics Export and Import
5.2 United States Pharmacogenomics Export and Import (2015-2020)
5.3 Europe Pharmacogenomics Export and Import (2015-2020)
5.4 China Pharmacogenomics Export and Import (2015-2020)
5.5 Japan Pharmacogenomics Export and Import (2015-2020)
5.6 India Pharmacogenomics Export and Import (2015-2020)
5.7 ...
6 Pharmacogenomics Market - By Type
6.1 Global Pharmacogenomics Production and Market Share by Types (2015-2020)
6.1.1 Global Pharmacogenomics Production by Types (2015-2020)
6.1.2 Global Pharmacogenomics Production Market Share by Types (2015-2020)
6.2 Global Pharmacogenomics Value and Market Share by Types (2015-2020)
6.2.1 Global Pharmacogenomics Value by Types (2015-2020)
6.2.2 Global Pharmacogenomics Value Market Share by Types (2015-2020)
6.3 Global Pharmacogenomics Production, Price and Growth Rate of DNA Sequencing (2015-2020)
6.4 Global Pharmacogenomics Production, Price and Growth Rate of Microarray (2015-2020)
6.5 Global Pharmacogenomics Production, Price and Growth Rate of Polymerase Chain Reaction (2015-2020)
6.6 Global Pharmacogenomics Production, Price and Growth Rate of Electrophoresis (2015-2020)
6.7 Global Pharmacogenomics Production, Price and Growth Rate of Mass Spectrometry (2015-2020)
6.8 Global Pharmacogenomics Production, Price and Growth Rate of Others (2015-2020)
7 Pharmacogenomics Market - By Application
7.1 Global Pharmacogenomics Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Pharmacogenomics Consumption by Applications (2015-2020)
7.1.2 Global Pharmacogenomics Consumption Market Share by Applications (2015-2020)
7.2 Global Pharmacogenomics Consumption and Growth Rate of Drug Discovery (2015-2020)
7.3 Global Pharmacogenomics Consumption and Growth Rate of Tailored Treatment (2015-2020)
7.4 Global Pharmacogenomics Consumption and Growth Rate of Oncology (2015-2020)
7.5 Global Pharmacogenomics Consumption and Growth Rate of Pain Management (2015-2020)
7.6 Global Pharmacogenomics Consumption and Growth Rate of Other Therapeutic Applications (2015-2020)
8 North America Pharmacogenomics Market
8.1 North America Pharmacogenomics Market Size
8.2 United States Pharmacogenomics Market Size
8.3 Canada Pharmacogenomics Market Size
8.4 Mexico Pharmacogenomics Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Pharmacogenomics Market Analysis
9.1 Europe Pharmacogenomics Market Size
9.2 Germany Pharmacogenomics Market Size
9.3 United Kingdom Pharmacogenomics Market Size
9.4 France Pharmacogenomics Market Size
9.5 Italy Pharmacogenomics Market Size
9.6 Spain Pharmacogenomics Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Pharmacogenomics Market Analysis
10.1 Asia-Pacific Pharmacogenomics Market Size
10.2 China Pharmacogenomics Market Size
10.3 Japan Pharmacogenomics Market Size
10.4 South Korea Pharmacogenomics Market Size
10.5 Southeast Asia Pharmacogenomics Market Size
10.6 India Pharmacogenomics Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Pharmacogenomics Market Analysis
11.1 Middle East and Africa Pharmacogenomics Market Size
11.2 Saudi Arabia Pharmacogenomics Market Size
11.3 UAE Pharmacogenomics Market Size
11.4 South Africa Pharmacogenomics Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Pharmacogenomics Market Analysis
12.1 South America Pharmacogenomics Market Size
12.2 Brazil Pharmacogenomics Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Affymetrix, Inc.
13.1.1 Affymetrix, Inc. Basic Information
13.1.2 Affymetrix, Inc. Product Profiles, Application and Specification
13.1.3 Affymetrix, Inc. Pharmacogenomics Market Performance (2015-2020)
13.2 Becton, Dickinson and Company
13.2.1 Becton, Dickinson and Company Basic Information
13.2.2 Becton, Dickinson and Company Product Profiles, Application and Specification
13.2.3 Becton, Dickinson and Company Pharmacogenomics Market Performance (2015-2020)
13.3 QIAGEN
13.3.1 QIAGEN Basic Information
13.3.2 QIAGEN Product Profiles, Application and Specification
13.3.3 QIAGEN Pharmacogenomics Market Performance (2015-2020)
13.4 Bayer AG
13.4.1 Bayer AG Basic Information
13.4.2 Bayer AG Product Profiles, Application and Specification
13.4.3 Bayer AG Pharmacogenomics Market Performance (2015-2020)
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Bio-Rad Laboratories, Inc. Basic Information
13.5.2 Bio-Rad Laboratories, Inc. Product Profiles, Application and Specification
13.5.3 Bio-Rad Laboratories, Inc. Pharmacogenomics Market Performance (2015-2020)
13.6 AstraZeneca PLC
13.6.1 AstraZeneca PLC Basic Information
13.6.2 AstraZeneca PLC Product Profiles, Application and Specification
13.6.3 AstraZeneca PLC Pharmacogenomics Market Performance (2015-2020)
13.7 Abbott Laboratories, Inc.
13.7.1 Abbott Laboratories, Inc. Basic Information
13.7.2 Abbott Laboratories, Inc. Product Profiles, Application and Specification
13.7.3 Abbott Laboratories, Inc. Pharmacogenomics Market Performance (2015-2020)
13.8 F. Hoffmann-La Roche AG
13.8.1 F. Hoffmann-La Roche AG Basic Information
13.8.2 F. Hoffmann-La Roche AG Product Profiles, Application and Specification
13.8.3 F. Hoffmann-La Roche AG Pharmacogenomics Market Performance (2015-2020)
13.9 Illumina, Inc.
13.9.1 Illumina, Inc. Basic Information
13.9.2 Illumina, Inc. Product Profiles, Application and Specification
13.9.3 Illumina, Inc. Pharmacogenomics Market Performance (2015-2020)
13.10 Thermo Fisher Scientific Inc.
13.10.1 Thermo Fisher Scientific Inc. Basic Information
13.10.2 Thermo Fisher Scientific Inc. Product Profiles, Application and Specification
13.10.3 Thermo Fisher Scientific Inc. Pharmacogenomics Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Pharmacogenomics Market Forecast (2020-2025)
14.2 Europe Pharmacogenomics Market Forecast (2020-2025)
14.3 Asia-Pacific Pharmacogenomics Market Forecast (2020-2025)
14.4 Middle East and Africa Pharmacogenomics Market Forecast (2020-2025)
14.5 South America Pharmacogenomics Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Pharmacogenomics Market Forecast by Types (2020-2025)
15.1.1 Global Pharmacogenomics Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Pharmacogenomics Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Pharmacogenomics Market Forecast by Applications (2020-2025)